Bio Essence (BIOE) EBITDA Margin (2020 - 2026)
Bio Essence (BIOE) recorded quarterly EBITDA Margin of 43.11% in Q1 2026, down 38.05% quarter-over-quarter from 69.6% in Q4 2025, and up 96741.0% on a YoY basis from N/an in Q1 2025.
Bio Essence (BIOE) EBITDA Margin (2020 - 2026) Analysis & Trends
Bio Essence's EBITDA Margin history runs 7 years deep, the most recent figure standing at 43.11% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 96741.0% year-over-year to 43.11%; the TTM figure through Mar 2026 stood at 55.6% (up 20372.0% YoY), while the FY2025 annual figure was 47.43%, up 18926.0% from the prior year.
- EBITDA Margin was 43.11% for Q1 2026 at Bio Essence, down from 69.6% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 95.31% in Q4 2023 to a low of 924.3% in Q1 2025.
- Historically, EBITDA Margin has averaged 95.68% across 5 years, with a median of 38.64% in 2022.
- The sharpest annual moves came in 2025 and 2026: EBITDA Margin plunged 82562 bps in 2025, then jumped 96741 bps in 2026.
- A 5-year view of EBITDA Margin shows it stood at 38.64% in 2022, then soared by 347 bps to 95.31% in 2023, then sank by 97 bps to 2.61% in 2024, then jumped by 2566 bps to 69.6% in 2025, then plunged by 38 bps to 43.11% in 2026.
- The last three EBITDA Margin figures came in at 43.11% (Q1 2026), 69.6% (Q4 2025), and 10.42% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -170.35% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Bio Essence | - | - | 319,353.00 | 43.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.11% |
| Dec 31, 2025 | 69.60% |
| Sep 30, 2025 | 10.42% |
| Jun 30, 2025 | 23.63% |
| Mar 31, 2025 | -924.30% |
| Dec 31, 2024 | 2.61% |
| Sep 30, 2024 | -108.73% |
| Jun 30, 2024 | -395.76% |
| Mar 31, 2024 | -98.68% |
| Dec 31, 2023 | 95.31% |
| Sep 30, 2023 | -53.08% |
| Jun 30, 2023 | -16.63% |
| Mar 31, 2023 | -7.12% |
| Dec 31, 2022 | -38.64% |
| Sep 30, 2022 | -100.27% |
| Jun 30, 2022 | -54.10% |
| Mar 31, 2022 | -73.90% |
| Dec 31, 2021 | -93.30% |
| Sep 30, 2021 | -85.00% |
| Jun 30, 2021 | -110.75% |